持田製薬株式会社 develops and sells pharmaceuticals and healthcare products. The company's offerings include skin care products and patient information websites, as well as services aimed at supporting various medical conditions.

持田製薬株式会社

Apple Mobile Web Clips Icon

DoubleClick.Net

CrUX Dataset

CrUX Top 50m

Google AdWords Conversion

Common Name Invalid

Google Conversion Linker

CrUX Top 5m

Google Remarketing

Bing Universal Event Tracking

Sales and Support

Arata Tabata

Business Management

Atsuo Matsunaga

Kazumi Hasegawa

Healthcare

Takashi Orido

Hideo Kanehiro

Hitoshi Yamashita

Keisuke Kido

Yoshitaka Fujishima

Chief Executive Director

Hiro Nakamura

Marketing and Product

Hiroshi Kyono

Naoyuki Mochida

President and CEO

Tokyo Medical Companies

Tokyo Companies With More Than 10 Employees (Top 10K)

Asia-Pacific (APAC) Companies With More Than 1000 Employees (Top 10K)

Japan Public Companies With More Than 500 Employees

Mochida Pharmaceutical is a drug manufacturing company. Their pharmaceutical business aims to develop and market a broad spectrum of innovative new drugs. They also offer creates skin care products for the general public, and these are supplied through pharmacies, and drugstores.

Toshima

Tokyo

Japan

Asia

Mochida Pharmaceutical

Non-controlling/minority interest of MOCHIDA PHARMACEUTICAL CO – TSE:4534 – TradingView

Total revenue of MOCHIDA PHARMACEUTICAL CO – TSE:4534 – TradingView

Diluted shares outstanding of MOCHIDA PHARMACEUTICAL CO – TSE:4534 – TradingView

Current ratio of MOCHIDA PHARMACEUTICAL CO – TSE:4534 – TradingView

Debt to equity ratio of MOCHIDA PHARMACEUTICAL CO – TSE:4534 – TradingView

Mochida Pharmaceutical (TSE:4534) Will Pay A Dividend Of ¥40.00

Hong Kong

Bangladesh

United States

North America

New Zealand

Oceania

Mochida Pharmaceutical Co., Ltd. produces and sells pharmaceuticals, skincare products, and diagnostics solutions in Japan. The company provides cardiovascular, analgesic, gastrointestinal, neurological, anti-infective, antidiabetics, and anticancer products, as well as hormone and biological preparations, and biosimilars; diagnostic reagents, such as reagents for fertility/infertility and other reagents; and face and body care, hair care, and skincare products, as well as dermatology, psychiatry, obstetrics, and gynecology products. It also developing drugs for the treatment of intractable diseases. The company has collaboration agreements with Amarin Corporation plc for the development and commercialization of ethyl icosapentate products; and Gene Techno Science Co., Ltd. to develop new regenerative medicine for the treatment of digestive rare and intractable diseases, such as congenital isolated hypoganglionosis. Mochida Pharmaceutical Co., Ltd. was founded in 1913 and is headquartered in Tokyo, Japan.

Mochida Pharmaceutical Co., Ltd.

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Sep 28, 2024 12:29 PM	028cf6df
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Sep 28, 2024 12:29 PM	124c47b4
crunchbase trigger	general	Nov 27, 2024 12:50 PM	6b5105c8
crunchbase profile	general	Nov 27, 2024 8:36 PM	157eea6b
li profile	general
translate crunchbase fundingrounds	general	Nov 27, 2024 10:24 PM	781bbfc8
peers	general	Sep 28, 2024 12:29 PM	34ce8d7d
news basic	general	Sep 28, 2024 12:29 PM	908c5a1b
bundesanzeiger	filings
financials download nd	financials
private financials	financials

JP:CO:MOCHIDA

持田製薬株式会社

Last Close

3,315.00

25/11 06:45

Market Cap

117.88B

Beta: -

Volume Today

19.20K

Avg: -